These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30372496)

  • 1. Correction: High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    Lee J; Yoon K; Ryu S; Chang Y; Kim HR
    PLoS One; 2018; 13(10):e0206834. PubMed ID: 30372496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men.
    Lee J; Yoon K; Ryu S; Chang Y; Kim HR
    PLoS One; 2017; 12(2):e0172666. PubMed ID: 28234943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease.
    McMahan RH; Porsche CE; Edwards MG; Rosen HR
    PLoS One; 2016; 11(12):e0168301. PubMed ID: 27930747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India.
    Bhatt SP; Guleria R; Vikram NK; Vivekanandhan S; Singh Y; Gupta AK
    PLoS One; 2018; 13(8):e0203182. PubMed ID: 30138466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients.
    Zimmermann E; Anty R; Tordjman J; Verrijken A; Gual P; Tran A; Iannelli A; Gugenheim J; Bedossa P; Francque S; Le Marchand-Brustel Y; Clement K; Van Gaal L; Sørensen TIA; Jess T
    J Hepatol; 2011 Sep; 55(3):660-665. PubMed ID: 21238518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    Romero-Ibarguengoitia ME; Vadillo-Ortega F; Caballero AE; Ibarra-González I; Herrera-Rosas A; Serratos-Canales MF; León-Hernández M; González-Chávez A; Mummidi S; Duggirala R; López-Alvarenga JC
    PLoS One; 2018; 13(5):e0198379. PubMed ID: 29795696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease.
    Yeniova AO; Küçükazman M; Ata N; Dal K; Kefeli A; Başyiğit S; Aktaş B; Ağladioğlu K; Akin KO; Ertugrul DT; Nazligül Y; Beyan E
    Hepatogastroenterology; 2014; 61(130):422-5. PubMed ID: 24901154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study.
    PLOS ONE Staff
    PLoS One; 2019; 14(2):e0212144. PubMed ID: 30721255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk for development of coronary artery calcification in subjects with non-alcoholic fatty liver disease and systemic inflammation.
    Kim J; Lee DY; Park SE; Park CY; Lee WY; Oh KW; Park SW; Rhee EJ
    PLoS One; 2017; 12(7):e0180118. PubMed ID: 28686633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis.
    Lee M; Kim W; Choi Y; Kim S; Kim D; Yu SJ; Lee JH; Kim HY; Jung YJ; Kim BG; Kim YJ; Yoon JH; Lee KL; Lee HS
    PLoS One; 2016; 11(11):e0167184. PubMed ID: 27861575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.
    Verrijken A; Francque S; Mertens I; Talloen M; Peiffer F; Van Gaal L
    Int J Obes (Lond); 2010 May; 34(5):899-907. PubMed ID: 20142825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
    Navarro VJ; Belle SH; D'Amato M; Afdhal N; Brunt EM; Fried MW; Rajender Reddy K; Wahed AS; Harrison S;
    PLoS One; 2019; 14(10):e0223915. PubMed ID: 31600349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver.
    Aizawa M; Inagaki S; Moriyama M; Asano K; Kakehashi M
    PLoS One; 2019; 14(12):e0226059. PubMed ID: 31790502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Survival from alcoholic hepatitis has not improved over time.
    Hughes E; Hopkins LJ; Parker R
    PLoS One; 2018; 13(4):e0195857. PubMed ID: 29634763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction: The Fatty Acid Synthase Inhibitor Platensimycin Improves Insulin Resistance without Inducing Liver Steatosis in Mice and Monkeys.
    Singh SB; Kang L; Nawrocki AR; Zhou D; Wu M; Previs S; Miller C; Liu H; Hines CD; Madeira M; Cao J; Herath K; Spears LD; Semenkovich CF; Wang L; Kelley DE; Li C; Guan HP
    PLoS One; 2017; 12(1):e0170721. PubMed ID: 28103304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease.
    Lee MS; Bae JM; Joo SK; Woo H; Lee DH; Jung YJ; Kim BG; Lee KL; Kim W
    PLoS One; 2018; 13(6):e0200055. PubMed ID: 29944727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight.
    Lee SM; Kim BJ; Koo JN; Norwitz ER; Oh IH; Kim SM; Kim SY; Kim GM; Kwak SH; Kim W; Joo SK; Shin S; Vixay C; Park CW; Jun JK; Park JS
    PLoS One; 2019; 14(10):e0224845. PubMed ID: 31665185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    Lowe PP; Gyongyosi B; Satishchandran A; Iracheta-Vellve A; Ambade A; Cho Y; Kodys K; Catalano D; Ward DV; Szabo G
    PLoS One; 2017; 12(5):e0179070. PubMed ID: 28562651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
    Targher G; Bertolini L; Scala L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Oct; 22(10):1354-8. PubMed ID: 16176196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Preliminary Validation of a High Docosahexaenoic Acid (DHA) and α-Linolenic Acid (ALA) Dietary Oil Blend: Tissue Fatty Acid Composition and Liver Proteome Response in Atlantic Salmon (Salmo salar) Smolts.
    PLOS ONE Staff
    PLoS One; 2018; 13(5):e0197800. PubMed ID: 29771968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.